- Home
- GHY vs QTRX Comparison
GHY vs QTRX Comparison
Compare GHY & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHY
- QTRX
- Stock Information
- Founded
- GHY 2012
- QTRX 2007
- Country
- GHY United States
- QTRX United States
- Employees
- GHY N/A
- QTRX N/A
- Industry
- GHY Trusts Except Educational Religious and Charitable
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- GHY Finance
- QTRX Industrials
- Exchange
- GHY Nasdaq
- QTRX Nasdaq
- Market Cap
- GHY 528.3M
- QTRX 439.1M
- IPO Year
- GHY N/A
- QTRX 2017
- Fundamental
- Price
- GHY $13.12
- QTRX $8.48
- Analyst Decision
- GHY
- QTRX Strong Buy
- Analyst Count
- GHY 0
- QTRX 4
- Target Price
- GHY N/A
- QTRX $23.25
- AVG Volume (30 Days)
- GHY 184.8K
- QTRX 987.8K
- Earning Date
- GHY 01-01-0001
- QTRX 03-17-2025
- Dividend Yield
- GHY 10.58%
- QTRX N/A
- EPS Growth
- GHY N/A
- QTRX N/A
- EPS
- GHY N/A
- QTRX N/A
- Revenue
- GHY N/A
- QTRX $133,809,000.00
- Revenue This Year
- GHY N/A
- QTRX $13.85
- Revenue Next Year
- GHY N/A
- QTRX $15.41
- P/E Ratio
- GHY N/A
- QTRX N/A
- Revenue Growth
- GHY N/A
- QTRX 14.72
- 52 Week Low
- GHY $10.24
- QTRX $8.21
- 52 Week High
- GHY $11.92
- QTRX $29.70
- Technical
- Relative Strength Index (RSI)
- GHY 55.61
- QTRX 36.68
- Support Level
- GHY $12.77
- QTRX $9.27
- Resistance Level
- GHY $13.45
- QTRX $9.92
- Average True Range (ATR)
- GHY 0.21
- QTRX 0.74
- MACD
- GHY 0.01
- QTRX 0.01
- Stochastic Oscillator
- GHY 53.33
- QTRX 28.44
About GHY PGIM Global High Yield Fund Inc.
PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.